Drupal.behaviors.print = function(context) {window.print();window.close();}>
Court Approves Sale of Correlogic’s Assets to Vermillion after Second Bidder Drops Out
December 02, 2011
Court Approves Sale of Correlogic’s Assets to Vermillion after Second Bidder Drops Out
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
Vermillion Buys Correlogic's Assets for $435K; Correlogic Settles with LabCorp, Quest
November 11, 2011 / ProteoMonitor
Is Healthlinx Eyeing Purchase of Correlogic's Assets as Part of Move into US Cancer Dx Market?
October 14, 2011 / ProteoMonitor
UPDATE: Vermillion Repays Quest $5.9M, Ending Companies' Credit Agreement
October 19, 2012 / ProteoMonitor
Healthlinx Signs $9M Financing Deal to Drive Expansion of OvPlex into US
December 16, 2011 / ProteoMonitor
HealthLinx Restarts Sales of OvPlex Ovarian Cancer Test, Launches 1,150-Patient International Trial
June 18, 2010 / ProteoMonitor